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ABSTRACT 
A selective and new spectrophotometric method is described for determination of three antiepileptic drugs; 
namely lamotrigine (LAM), gabapentin (GAB), and oxcarbazepine (OXC) in drug substances and in drug products using 
vanillin reagent as the chromogenic agent.The method is based on a coupling reaction between the cited drugs and 
vanillin reagent in acidic condition. Under optimized conditions, the yellow colored products were measured at 405, 396, 
and 400 nm respectively. Beer’s law was obeyed at (0.4 – 10), (0.1-10), and (0.5-11) μg/mL, and  the calculated molar 
absorptivity values are 2.52 x 10
4
, 1.74 x 10
4
, and 2.54 x 10
4
 L/mol/cm for LAM, GAB, and OXC respectively. Sandell 
sensitivity, the limit of detection (LOD) and limit of quantification (LOQ) were calculated. No interference was observed 
from common additives found in drug products. The presented method was validated according to ICH guidelines. 
Statistical comparison of the results was performed using Student's  t-test and F-ratio at 95% confidence level, and there 
was no significant difference between the reference and proposed method with regard to accuracy and prec ision. The 
method offers the advantages of rapidity, simplicity and sensitivity and low cost and can be easily applied to resource poor 
settings without the need for expensive instrumentation and reagents. 
Keywords: Antiepileptic drugs; Chromogenic agent; ICH guidelines; Statistical comparison; Spectrophotometric 
method; Vanillin reagent. 
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1. INTRODUCTION: 
Lamotrigine (LAM), 3, 5-diamino-6-(2, 3-dichlorophenyl)-1, 2, 4-triazine Figure 1is an anticonvulsant drug. As an 
antiepileptic, it has been used successfully to treat epilepsy and bipolar disorder as immunotherapy and as an adjunct with 
other antiepileptic for treatment of partial and generalized toxic-chronic seizures. It is also used to treat neurological 
lesions and as a tranquilizer [1, 2]. LAM is the subject of monographs in the United States Pharmacopeia[3] where by 
potentiometric method is recommended for its determination. Several analytical methods have been reported for the 
determination of LAM in pharmaceuticals or in biological fluids including reverse -phase HPLC [4-6], GC with nitrogen 
phosphorous detector[7], capillary electrophoresis[8], adsorptive stripping voltammetry[9,10] and  spectrophotometry[11-
17]. The objective of the present work is to develop simple, rapid and precise UV spectroscopic method for the 
determination of lamotrigine in drug substance and in drug products .  
The new anti-convulsion drug Gabapentin (1-(amino methyl) cyclohexane acetic acid) Figure 1 is a structural 
analogue of amino butyric acid (GABA) and its action is attributed to the irreversible inhibition of the enzyme GABA-
transaminase, thus preventing the physiological degradation of GABA in the brain. [18] Currently, GAB and its 
pharmaceutical dosage forms are official in the United States Pharmacopeia and also different analytical methods are 
reported for its determination. These include high performance liquid chromatography [3], liquid chromatography-mass 
spectrometry [19], gas chromatography mass spectrometry [20], capillary electrophoresis [21], potentiometric [22], 
spectrofluorimetric [23], and colorimetric. [24-27]. Literature survey does not reveal any simple extractive spectroscopic 
method for determination of GBP. The present manuscript describes simple and sensitive spectroscopic procedures fo r 
the determination of GAB in drug products.  
Oxcarbazepine (10, 11-dihydro-10-oxo-5H-dibenzo [b, f] aze-pine-5-carboxamide), Figure 1.An antiepileptic drug, 
official in the United States Pharmacopeia [3] is a 10-keto analogue of carbamazepine with a similar therapeutic profile, 
but with less adverse effects and less clinical relevant pharmacokinetic drug interactions [28]. OXC is indicated as first line 
drug in immunotherapy or polytherapy for the treatment of partial seizures with or without secondarily generalized tonic 
colonic epileptic seizures [29-30]. These actions are thought to be important in the prevention of synaptic 
neurotransmission and seizure spread in the intact brain [31]. In addition,increased potassium conductance and 
modulation of high voltage activated calcium channels may contribute to the anticonvulsant effects of the drug [32]. There 
is LC, GC, voltammetry, HPLCand several other methods for the quantification of oxcarbazepine and its main metabolites 
10-hydroxy-10, 11- dihydrocarbamazepine and 10, 11- dihydroxy-trans-10, 11- dihydrocarbamazepine in biological fluids, 
which are reported [33-40], another method spectrophotometry[41-42] and voltammetry[43]. To our knowledge most of the 
reported methods mainly describe the determination of OXC in biological fluids but only a few methods are describing its 
determination in pharmaceutical formulations.  In addition some of those methods are requiring expensive equipment, 
reagents and are also time consuming; an attempt is made here to develop a simple, rapid, economical and sensitive 
spectrophotometric method based on the reaction of OXC with vanillin in acidic medium for its determination either in pure 
or in dosage form. 
Vanillin (4-hydroxy-3- methoxybenzaldehyde) Figure 1   is an organic compound containing an aldehyde, ether 
and phenolic moiety. It has been used as a chemical intermediate in the production of pharmaceuticals and other 
chemicals. It is also used as a general purpose stain for TLC plate development to aid visualization. Use of it has also 
been reported in the quantitative determination of certain drugs by spectrophotometric reaction [44-49]. 
 
 
 
(a)                                           (b)                                           (c ) 
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Figure 1:Chemical structures of the investigated antiepileptic drugs (a) lamotrigine, (b) gabapentin, (c) 
oxcarbazepine and (d) vanillin reagent. 
 
2. EXPERIMENTAL PROCEDURES: 
2.1. Instrument 
SHIMADZU UV-2450 PC Series Spectrophotometer (Tokyo – Japan) with two matched 1 cm quartz cells using 
the following spectral parameters: Scan mode: absorbance, Speed: fast and Slit width: 2 nm 
2.2. Materials and Chemicals  
Lamotrigine (Batch no: 14LM000002) was kindly supplied by Delta Pharm and assayed for purity according to the 
official HPLC assay [3] to contain 99.95%±0.12%. Larogen 100 mg/tab. (B.N. 13691), manufactured by Delta Pharm. 
Gabapentin (Batch no: 20121004) was kindly supplied by Mash Pharm. industry and assayed for purity according to the 
official HPLC assay [3] to contain 98.85%±0.23%. Gaptin 100 mg/tab. (B.N. GA102) manufactured by Delta Pharm.  
Oxcarbazepine (Batch no: OX0010514) was kindly supplied by Mash Pharm pharmaceutical industry and assayed for 
purity according to the official HPLC assay [3] to contain 99.87%±0.28%. Trileptal 150 mg/tab. (B.N. 10000), manufactured 
by Novartis Com. 
All chemicals are analytical grad, Methanol (LAB-SCAN), Hydrochloric acid 37% (Honeywell), and Vanillin 
(Qualikems Fine Chemicals Pvt. Lid), Prepared by dissolving 5 gm. of vanillin in 100.0 mL of 1.0 M methanolic 
hydrochloric acid. 
2.3. Standard Stock Solution of Drugs 
Accurately about 20 mg of the drug substances (LAM, GAB, OXC) was weighed and dissolved in 1.0 M 
methanolic hydrochloric acid and the volume is made up to the volume 100 ml to give standard stock solution (200µg/ml) 
and from this solution 10 ml of sample was transferred in to separated 100 ml volumetric flask and volume was made up to 
the mark 100 ml with 1.0 M methanolic hydrochloric acid to get concentration (20µg/ml) as a working stander solution. 
2.4. Procedure for Calibration Curves  
An aliquot of 1.0 mL of the working stander solutions was transferred into a 10-mL calibrated flask, 2.0 mL of 5% 
vanillin reagent was added, mixed well, the reaction was allowed to stand for about15 minutes, then the resulting colored 
products were measured at 405, 396, and 400 nm for LAM, GAB, and OXC respectively against blanks which treated 
similarly. 
2.5. Procedure for the Assay of Drug Products 
Twenty tablets were weighted accurately, the contents were mixed thoroughly.An accurate weight of the mixed 
powder equivalent to one tablet of LAM, GAB, and OXC were transferred into three separated 100-ml conical flasks, 50-ml 
1M methanolic hydrochloric acid was added,  The contents were swirled and sonicated for 10 min, then filtered through a 
What- mann No. 42 filter paper previously moisten with methanol. The collected filtrate was transferred quantitatively into 
100-mL calibrated flask; the resultant solutions were completed to mark with 1.0 M methanolic hydrochloric acid and then 
subjected to subsequent dilution. 
3. RESULTS AND DISCUSSION 
3.1. Absorption Spectra 
LAM, GAB, and OXC readily reacts with vanillin in methanolic hydrochloric acid solution yielding an intense 
yellow colored hydrazone as shown in the equation having an absorption maximum at 405,396, and400 nm (Schema 1).   
The reagent blank does not absorb around this wavelength. The hydrazone formed was stable in the temperature range 
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20 – 40
0
C. The color of the products formed was stable for about 2 hours at room temperature (30
0
C) followed by a steady 
decrease in absorbance values as shown in Figure 2. 
 
Scheme 1: Probable reaction scheme. 
 
 
 
 
Figure 2:Absorption spectra of LAM (10 µgml
-1
), GAB (6µgml
-1
), and OXC (5µgml
-1
) - Vanillin (5 %w/v) reaction 
product. 
 
3.2. Optimization of Experimental Variables 
Various experimental variables were optimized to achieve maximum sensitivity.  
3.2.1. Determination of effective reagent concentration  
Preliminary experiments were done in order to ascertain the effect of concentration and the volume of vanillin at 
the wavelength of maximum absorption, 405,396, and 400nm. To series of LAM, GAB, and OXC solutions, varying 
concentrations (1-7%) were added and the analytical procedure followed. After 15 minutes, the absorbance of each 
solution of three drugs was read at 405,396, and 400nm. It was observed that the analytical signal increased with an 
increase in reagent concentration up to 6%. The concentration of vanillin therefore utilized was 5%.       Similarly, by fixing 
the vanillin concentration as 5% in series of LAM, GAB, and OXC solutions, different volumes of vanillin in the range of 0.5 
– 4 ml were added. The analytical procedure was then followed, after 15 minutes, the absorbance was read. It was 
observed that 2-ml of 5% vanillin solution was optimal for the formation of color with maximum intensity. Therefore, 2 -ml of 
5% vanillin solution was utilized for all measurements  as shown inFigure 3. 
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Figure 3:Effect of conc. of (2-ml) of Vanillin in absorbance of LAM (10 µgml
-1
), GAB (6µgml
-1
), and OXC (5µgml
-1
) –
Vanillin (5% w/v) reaction products.  
3.2.2. Types of acids  
Reaction between vanillin reagent and antiepileptic drugs was found to proceed in  acidic medium. So, different 
acids were tested.   1.0 M methanolic Hydrochloric acid resulted in an increase of the absorbance intensity accompanied 
by hyper chromic shift as shown inFigure 4. 
 
Figure 4: Effect of different acids on absorbance of LAM (10 µgml
-1
), GAB (6µgml
-1
), and OXC (5µgml
-1
) –Vanillin 
(5% w/v) reaction products. 
3.2.3. Effect of reaction time 
The effect of time on the reaction was studied by carrying out the reaction for different periods of time (0 -30 min). 
The reaction product’s absorbance of LAM, GAB, and OXC with vanillin wasincreased by increasing the time up to 20min. 
The color of the products formed was stable for about 2 hours at room temperature (30
0
C) followed by a steady decrease 
in absorbance values as shown in Figure 5. 
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Figure 5: Effect of reaction time on absorbance of LAM (6 µgml
- 1
), GAB (4µgml
-1
), and OXC (3µgml
-1
) –Vanillin (5% 
w/v) reaction products. 
3.2.4. Stability of the chromophore  
 After dilution the reaction solutions, it was found that the absorbance of the chromophore (LAM-vanillin), (GAB-
vanillin), and (OXC-vanillin) remained stable for at least 2 hours. Under the optimum experimental conditions the 
calibration curves were plotted representing the relationship between the absorbance at 405, 396 and 400 nm and the 
corresponding concentration of the three cited drugs (LAM, GAB, and OXC).  Linear correlation coefficients were obtained 
within the concentration range (0.4 – 10), (0.1-10), and (0.5-11) μg/mLfor LAM, GAB, and OXC respectively. 
3.2.5. Stoichiometry of the reaction  
 Under the optimum conditions, the stoichiometry of the reaction of LAM, GAB, and OXC with vani llin were 
determined adopting the Job's method of continuous variation [50]. The results revealed that LAM, GAB, and OXA reacted 
with vanillin in a ratio of 1:1 under the optimum condition attained Figure 6. 
 
Figure 6:Determination of Stoichiometry of the reaction of LAM, GAB, and OXC– vanillin (5% w/v) by Continuous 
Variation method using (2 x 10
-4
 M) solutions. 
 
3.2.6. Determination of the stability constant 
The stability constant (Kf) of the reaction products are calculated according to the follow equation:             
Kf   = (A / Am) ⁄ [1 –A / Am] n
-1
C
n
n
n
[51] 
Where: A = maximum absorbance of the continuous variation curve Figure 6, Am = absorbance corresponding to 
intersection of two tangents of the continuous variation curve, n = number of molecules of the reagent in the reaction 
product, C = molar concentration of the drug and K f= formation constant of the complex.   
The stability constant of the reaction products of LAM, GAB and OXC with vanillin were 4.2 x 10
4
, 1.8 x 10
4
, and 
2.4 x 10
3
, respectively.  
The Gibbs free energy change of the reaction (ΔG) [52] was also calculated adopting the following equation:           
ΔG = - 2.303 R T log Kf  
  Where:     ΔG = Gibbs free energy change of the reaction (k.J. mol -1) 
                                 R   = Universal gas constant (8.314 joules) 
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                                 T   = Absolute temperature (273+25
o
C) 
Kf = Formation constant of reaction 
The free energy changes (ΔG) of the reaction LAM, GAB and OXC with vanillin was found to be – 6.3 x 10
4
, - 5.8 x 10
4
 
and – 4.6 x 10
4
 k.J.mole
-1
 respectively, The higher Kf and ΔG values obtained indicate very stable reaction products. 
3.3. Method Validation 
3.3.1. Analytical Parameters 
A linear relation was found to exist between absorbance and the concentration of LAM, GAB, and OXC in the 
range (0.4 – 10), (0.1-10), and (0.5-11) μg/mLrespectively. The calibration graph is described by the equation: Y = a+bC 
(where Y is the absorbance, a is the intercept, b is the slope and C is the concentration in μg/mL) obtained by the method 
of least squares. Correlation coefficient, intercept and slope for the calibration data are summarized in Table 1. Sensitivity 
parameters such as apparent molar absorptivity and Sandell’s sensitivity values, the limits of detection and quantification 
calculated as per the current ICH Q2B guidelines [53] are compiled in Table 1 and are indicative of the excellent sensitivity 
of the method. The limits of detection (LOD) and quantification (LOQ) were calculated according to the same guidelines 
using the formulae: LOD = 3.3σ /b and LOQ = 10 σ /b, where b is slope of the calibration curve and σ is standard deviation 
of y-intercept of regression equation Table 1. 
 
Table 1:Sensitivity and regression parameters 
Parameters Lamotrigine  Gabapentin Oxcarbazepine 
ʎ max 
Molar absorptivity (L mol
-1
 cm
-1
) 
Sandell sensitivity ( µcm
-2
 /0.001 abs unit  ) 
405.0nm 
2.52x10
4
 
10.23x10
-3
 
396.0 nm 
1.74x 10
3
 
9.71x10
-3
 
400.0 nm 
2.54x10
4
 
9.82x10
-3
 
Regression equation (Y= bC+ a) 
Slope (b) 
SD of slope 
S E of slope 
Confidence limit of slope  
Intercept (a) 
SD of Intercept 
S E of Intercept  
Confidence limit of Intercept 
Correlation coefficient (r ) 
SE of ( r)  
 
0.0985 
0.000135 
0.000555 
0.09718 – 0.09989 
- 0.001 
0.007153 
0.002921 
-0.00815 – 0.00615 
0.9998 
0.00533 
 
 
0.1017 
0.00083 
0.00034 
0.10083 – 0.10249 
0.0034 
0.004378 
0.001788 
-0.00095-0.0078 
0.9999 
0.00334 
 
0.1007 
0.00195 
0.00079 
0.09866 – 0.10275 
0.0043 
0.0125 
0.00508 
-0.00173 –0.01738 
0.9997 
0.00779 
 
Validation parameters 
Selectivity and Specificity 
(t-test) (2.228) 
Accuracy (Mean
c
 ± RSD %) 
Linearity (µg /ml) 
Limit of detection [LOD]  
Limit of quantitation [LOQ]  
Robustness(mean% recovery ±S.D) 
 
0.175 
 
99.845 ± 0.867 % 
0.4 -10.0 µg /ml 
0.165 µg /ml 
0.500 µg /ml 
100.11% ± 0.545 
 
1.15 
 
99.0 ± 0.957 % 
0.1 -10.0 µg /ml 
0.049 µg /ml 
0.150 µg /ml 
100.08% ± 0.416 
 
0.491 
 
99.916 ± 0.862% 
0.5 -11.0 µg /ml 
0.188 µg /ml 
0.570 µg /ml 
100.4% ± 0.583 
Y = bC + a where C is the concentration of three drugs in µg /ml and Y is absorbance unit. (Each value is a result of six 
separate determinations), c 95% confidence limit. 
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3.3.2. Accuracy 
The accuracy of the proposed method for drug substances and drug products was determined by investigating 
the percentage recovery at five levels each three times in the concentration range 3.0 -11.0µg/ml as shown in Table 2.  
The percentage relative standard deviation (% RSD) revealed high accuracy. 
 
Table 2: Accuracy of the proposed method in drug substances and drug products 
 
Conc. 
taken 
μg /ml 
 
Lamotrigine  Gabapentin Oxcarbazepine 
Drug subs. Drug product Drug subs. Drug product Drug subs. Drug product 
Laroge 
100 mg/tab 
Gaptin 
100 mg/tab. 
Trileptal 
150 mg/tab. 
Recovery (%)
a
 Recovery (%)
a
 Recovery (%)
a
 
3 99.23 99.51 98.33 99.67 99.52 99.11 
5 99.56 98.72 98.91 98.31 98.92 98.64 
7 98.21 99.66 98.73 97.99 100.02 99.09 
9 97.75 98.90 99.64 99.12 101.0 99.82 
11 100.0 98.81 101.0 99.25 99.76 98.76 
Mean± 
RSD% 
98.95 
± 0.951 
99.12 
± 0.436 
99.32 
± 1.05 
98.87 
± 0.703 
99.84± 
0.765 
99.08 
± 0.463 
 
a
Average from four different experiments. For drug product, recovery is given as a percentage of the amount claimed 
table. 
 
3.3.3. Precision  
The intraday precision was evaluated by assaying freshly prepared solutions in triplicate in the concentration 
range 2.0 -16.0µg/ml as shown in Table 3. The percentage relative standard deviations (%RSD) were calculated. While 
interday precision was calculated by assaying freshly prepared solutions in triplicate for three days. The percentage 
relative standard deviations (%RSD) were calculated as shown in Table 3. 
Table 3:  Evaluation of intra-day and inter-day of precision 
 
Drug 
taken 
µg 
/ml 
Lamotrigine  Gabapentin Oxcarbazepine 
Intra-day 
accuracy and 
precision 
Inter-day 
accuracy and 
precision 
Intra-day accuracy 
and precision 
Inter-day accuracy 
and precision 
Intra-day 
accuracy and 
precision 
Inter-day 
accuracy and 
precision 
Lam. 
found 
RSD% Lam. 
found 
RSD% Gab. 
found 
RSD% Gab. 
found 
RSD% Oxc. 
found 
RSD% Oxc. 
found 
RSD% 
4 4.02 0.123 3.90 0.505 4.00 0.214 3.89 0.641 4.06 0.136 3.95 0.321 
6 6.10 0.265 6.01 0.541 6.05 0.341 5.97 0.521 6.03 0.710 5.94 0.221 
8 8.01 0.348 8.04 0.364 7.90 0.721 7.99 0.543 8.01 0.213 8.00 0.334 
RSD%: relative standard deviation. 
 
3.3.4. Robustness and ruggedness  
Method robustness was tested by making small incremental changes in volume of vanillin rang of Temp. To 
check the ruggedness, analysis was performed by three different analysts and on three different spectrophotometers by 
the same analyst. The robustness and the ruggedness were checked at three different drugs levels. The intermediate 
precision, expressed as percent RSD, which is a measure of robustness and ruggedness was within the acceptabl e limits 
as shown in the Table 4. 
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Table 4: Robustness and ruggedness expressed as intermediate precision (% RSD) 
 
 
Drugs 
Method Robustness Method Ruggedness 
Parameters altered 
Vanillina (5%) 
 ml, 
RSD % (n=3) 
Change in 
Tempb.(30oC) 
RSD % (n=3) 
Inter-analysts’ 
RSD % (n=3) 
Inter-instruments’ 
RSD % (n= 3) 
Lamotrigine 0.755% 0.252% 0.261% 0.448% 
Gabapentin 0.843% 0.836% 0.684% 0.297% 
Oxcarbazepine 0.794% 0.504% 0.107% 0.905 
a= vanillin volumes were used 2.1, 2.3, 2.5 ml. 
 b= change in Temp. 30.2, 30.4, 30.6 
o
C. 
 
3.3.5. Method Validation for Drug Products  
 It is evident from the above-mentioned results that the proposed method gave satisfactory results with LAM, 
GAB, and OXC in its drug substances. Thus its drug products were subjected to the analysis of their LAM, GAB, and OXC 
contents by the proposed and the potentiometric method for LAM (4), official HPLC method for GAB (4) and official HPLC 
method for OXC (28).  The label claim percentages were 99.12 ± 0.436%, 99.32 ± 1.05%, and 99.08 ± 0.463% for LAM, 
GAB, and OXC, respectively Table 5. These results were compared with those obtained from the official methods by 
statistical analysis with respect to the accuracy (by t- test) and precision (by F- test). No significant differenceswere found 
between the calculated and theoretical values of t-test and F-test at 95% confidence level proving similar accuracy and 
precision in the determination of LAM, GAB and OXC by UV method.  
Table 5: Results of analysis of tablets by the proposed method 
 Lamotrigine  
Larogen 
100 mg/tab 
Gabapentin 
Gaptin 
100 mg/tab. 
Oxcarbazepine 
Trileptal 
150 mg/tab. 
proposed 
method 
HPLC  
method [3] 
proposed method HPLC 
method [3] 
Proposed 
method 
HPLC 
method [3] 
Mean* 
± RSD% 
99.57± 
0.483% 
99.53± 
0.49% 
99.77± 
0.216% 
99.65± 
0.182% 
99.61± 
0.272% 
99.54± 
0.253% 
Variance 0.231 0.238 0.046 0.033 0.073 0.064 
SE 0.196 0.199 0.086 0.074 0.111 0.103 
t-test 
(2.228)
a
 
0.144  0.902  0.461  
F-test 
(5.1)
a
 
1.030  1.39  1.14  
 
Average of six different experiments                    a) Theoretical values 
 
4. CONCLUSION 
A simple, sensitive and rapid method for the determination of LAM, GAB and OXC in its drug products are 
described, involving the use of vanillin as a chromogenic agent. The method is rapid and less tedious than many reported 
spectrophotometric methods. The present method can be applied at ambient temperature; color development is 
instantaneous and does not require strict pH control or tedious liquid -liquid extraction step. The method employs 
inexpensive and easily available chemicals and instrument. As most relevant features of the method, hig h sensitivity and a 
wide linear dynamic range compared to many existing methods can be emphasized. The color formed is highly stable 
leading to very precise results.  These advantages make the method a valuable alternative to many existing methods for 
the determination of LAM, GAB and OXC in drug substances and can be applied in biological fluids. 
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